Indications: Acute Lymphocytic Leukemia (ALL), Non-Hodgkin’s Lymphomas, Osteogenic Sarcoma, Breast Cancer, Head and Neck Cancer, Choriocarcinoma, Trophoblastic, Advanced Cancer of Urinary Bladder
Methotrexate is indicated for the treatment of acute lymphocytic leukemia (ALL), non-hodgkin’s lymphomas, osteogenic sarcoma, breast cancer, head and neck cancer, choriocarcinoma, trophoblastic, and advanced cancer of urinary bladder.
